Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T9911 |
Tocilizumab
|
Interleukin | Immunology/Inflammation |
Tocilizumab 是抗人白细胞介素-6 受体 (IL-6R) 的中和抗体,能够阻碍 IL-6 与 IL-6R 的结合,进而抑制经典和反式信号。它可用于研究类风湿性关节炎,对重症 COVID-19 冠状病毒病方面的研究具有显著效果。 | |||
TP1016L |
Aviptadil Acetate
醋酸阿肽地尔,阿肽地尔,Vasoactive Intestinal Peptide acetate salt |
RAAS; SARS-CoV | Endocrinology/Hormones; Microbiology/Virology |
Aviptadil Acetate (Vasoactive Intestinal Peptide acetate salt) 是模拟血管活性肠多肽类似物,具有血管舒张效应。它可诱导肺血管舒张并抑制血管 SMC 的增殖和血小板聚集。它可用于研究 SARS-CoV-2 引起的肺纤维化、肺动脉高压和呼吸衰竭。 | |||
T76690 |
Mavrilimumab
CAM 3001 |
Virus Protease; CSF-1R | Microbiology/Virology; Tyrosine Kinase/Adaptors |
Mavrilimumab (CAM 3001) 是一种单克隆抗体,具有抗病毒活性,对粒细胞-巨噬细胞集落刺激因子 (GM-CSF) 受体的 α 亚基有亲和力,并阻止 GM-CSF 下游细胞内信号传导。GM-CSF 可能与呼吸衰竭和死亡相关的过度活跃炎症反应有关,可用于研究类风湿性关节炎。 | |||
T21414 |
Sivelestat sodium
ONO 5046,LY-544349,Sivelestat sodium salt,ONO-5046,ONO5046,西维来司钠,LY544349,LY 544349 |
||
Sivelestat, an inhibitor of human neutrophil elastase, is used in the treatment of acute respiratory failure. Preliminary studies show Sivelestat may improve neuropathic pain. | |||
T69786 |
GSK3491943
|
||
GSK3491943 is a potent TRPV4 inhibitor with IC50 = 3.2 nM. GSK3491943 is a potential agent for the treatment of heart failure and respiratory diseases. | |||
T69784 |
GSK3527497 HCl
|
||
GSK3527497 is a potent and selective inhibitor of Transient Receptor Potential Vanilloid‑4 (TRPV4) with IC50 = 12 nM) for the treatment of heart failure and respiratory diseases. GSK3527497 is a preclinical candidate suitable for oral and iv administration that is projected to inhibit TRPV4 effectively in patients from a low daily clinical dose. |